Molecular Templates to Present at the 2017 BIO Inv
Post# of 301275
AUSTIN, Texas, Oct. 06, 2017 (GLOBE NEWSWIRE) -- Molecular Templates, Inc., (Nasdaq: MTEM ) a clinical stage biopharmaceutical company focused on the discovery and development of Engineered Toxin Bodies (ETBs), a new class of targeted biologic therapies that possess unique mechanisms of action in oncology, today announced that Eric E. Poma, Ph.D., Chief Executive and Chief Scientific Officer, will provide a corporate overview at the 2017 BIO Investor Forum, being held October 17-18 in San Francisco, California.
BIO Investor Forum Date: Tuesday, October 17 Time: 10:30am Pacific Time Location: Westin St. Francis, San Francisco, Elizabethan C Ballroom Webcast: http://www.veracast.com/webcasts/bio/investor...335172.cfm
About Molecular Templates Molecular Templates is focused on the discovery, development and commercialization of next-generation immunotoxins called Engineered Toxin Bodies (ETBs) for the treatment of cancers and other serious diseases. For additional information, please visit Molecular Templates’ website at www.mtem.com .
Investor Contact: Andrew McDonald, Ph.D. andrew@lifesciadvisors.com 646-597-6987
(0)
(0)